Altimmune, Inc.
Developing novel peptide therapeutics for obesity, liver, and cardiometabolic diseases.
ALT | NDAQ
Overview
Corporate Details
- ISIN(s):
- US02155H1014 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 910 CLOPPER ROAD, 20878 GAITHERSBURG
- Website:
- https://altimmune.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics. The company's primary efforts are directed towards creating treatments for liver diseases, obesity, and cardiometabolic conditions. Its lead product candidate, pemvidutide, is being developed for multiple indications, including metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Altimmune, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Altimmune, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Altimmune, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
